A citation-based method for searching scientific literature

Donghyuk Shin, Rukmini Mukherjee, Diana Grewe, Denisa Bojkova, Kheewoong Baek, Anshu Bhattacharya, Laura Schulz, Marek Widera, Ahmad Reza Mehdipour, Georg Tascher, Paul P Geurink, Alexander Wilhelm, Gerbrand J van der Heden van Noort, Huib Ovaa, Stefan Müller, Klaus-Peter Knobeloch, Krishnaraj Rajalingam, Brenda A Schulman, Jindrich Cinatl, Gerhard Hummer, Sandra Ciesek, Ivan Dikic. Nature 2020
Times Cited: 408



Chunlong Ma, Michael Dominic Sacco, Brett Hurst, Julia Alma Townsend, Yanmei Hu, Tommy Szeto, Xiujun Zhang, Bart Tarbet, Michael Thomas Marty, Yu Chen, Jun Wang. Cell Res 2020
Times Cited: 370




List of shared articles



Times cited

Medicinal chemistry strategies towards the development of effective SARS-CoV-2 inhibitors.
Shenghua Gao, Tianguang Huang, Letian Song, Shujing Xu, Yusen Cheng, Srinivasulu Cherukupalli, Dongwei Kang, Tong Zhao, Lin Sun, Jian Zhang,[...]. Acta Pharm Sin B 2022
7

Design of SARS-CoV-2 PLpro Inhibitors for COVID-19 Antiviral Therapy Leveraging Binding Cooperativity.
Zhengnan Shen, Kiira Ratia, Laura Cooper, Deyu Kong, Hyun Lee, Youngjin Kwon, Yangfeng Li, Saad Alqarni, Fei Huang, Oleksii Dubrovskyi,[...]. J Med Chem 2022
24

Structure-based identification of naphthoquinones and derivatives as novel inhibitors of main protease Mpro and papain-like protease PLpro of SARS-CoV-2.
Lucianna H Santos, Thales Kronenberger, Renata G Almeida, Elany B Silva, Rafael E O Rocha, Joyce C Oliveira, Luiza V Barreto, Danielle Skinner, Pavla Fajtová, Miriam A Giardini,[...]. bioRxiv 2022
0

Virtual screening of natural products inspired in-house library to discover potential lead molecules against the SARS-CoV-2 main protease.
Aakriti Garg, Narender Goel, Nipun Abhinav, Tanmay Varma, Anushree Achari, Pinaki Bhattacharjee, Izaz Monir Kamal, Saikat Chakrabarti, Velayutham Ravichandiran, Araveeti Madhusudhana Reddy,[...]. J Biomol Struct Dyn 2022
1

Drug repurposing against SARS-CoV-2 using computational approaches.
Sumit Kumar, Svitlana Kovalenko, Shakshi Bhardwaj, Aaftaab Sethi, Nikolay Yu Gorobets, Sergey M Desenko, Poonam, Brijesh Rathi. Drug Discov Today 2022
3

DrugDevCovid19: An Atlas of Anti-COVID-19 Compounds Derived by Computer-Aided Drug Design.
Yang Liu, Jianhong Gan, Rongqi Wang, Xiaocong Yang, Zhixiong Xiao, Yang Cao. Molecules 2022
2

Validation and Invalidation of SARS-CoV-2 Papain-like Protease Inhibitors.
Chunlong Ma, Jun Wang. ACS Pharmacol Transl Sci 2022
10

Targeting SARS-CoV-2 Proteases for COVID-19 Antiviral Development.
Zongyang Lv, Kristin E Cano, Lijia Jia, Marcin Drag, Tony T Huang, Shaun K Olsen. Front Chem 2022
4

Targeting the Ubiquitylation and ISGylation Machinery for the Treatment of COVID-19.
George Vere, Md Rashadul Alam, Sam Farrar, Rachel Kealy, Benedikt M Kessler, Darragh P O'Brien, Adán Pinto-Fernández. Biomolecules 2022
1

Drug-Repurposing Screening Identified Tropifexor as a SARS-CoV-2 Papain-like Protease Inhibitor.
Chunlong Ma, Yanmei Hu, Yuyin Wang, Juliana Choza, Jun Wang. ACS Infect Dis 2022
1

Insights into the binding and covalent inhibition mechanism of PF-07321332 to SARS-CoV-2 Mpro.
Son Tung Ngo, Trung Hai Nguyen, Nguyen Thanh Tung, Binh Khanh Mai. RSC Adv 2022
0

Antiviral cyclic peptides targeting the main protease of SARS-CoV-2.
Jason Johansen-Leete, Sven Ullrich, Sarah E Fry, Rebecca Frkic, Max J Bedding, Anupriya Aggarwal, Anneliese S Ashhurst, Kasuni B Ekanayake, Mithun C Mahawaththa, Vishnu M Sasi,[...]. Chem Sci 2022
3